Bicycle Therapeutics plc logo
Bicycle Therapeutics plc BCYC
$ 14.72 -1.87%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Bicycle Therapeutics plc Financial Statements 2011-2024 | BCYC

Annual Financial Statements Bicycle Therapeutics plc

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

802 M 680 M 1.22 B 513 M 121 M - - - - - - - -

Shares

35.6 M 29.7 M 25.1 M 19.1 M 11 M - - - - - - - -

Historical Prices

22.5 22.9 48.8 26.8 10.9 - - - - - - - -

Net Income

-181 M -113 M -66.8 M -51 M -30.6 M -21.8 M -16.3 M - - - - - -

Revenue

27 M 14.5 M 11.7 M 10.4 M 13.8 M 7.14 M 2.06 M - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-190 M -117 M -65.6 M -52 M -26.3 M -21.7 M -16.2 M - - - - - -

Interest Expense

3.26 M 3.34 M 2.98 M 457 K -5.38 M -665 K -119 K - - - - - -

EBITDA

-183 M -113 M -64.2 M -50.7 M -25.3 M -21 M -15.9 M - - - - - -

Operating Expenses

217 M 131 M 77.3 M 62.4 M 40.1 M 28.9 M 18.3 M - - - - - -

General and Administrative Expenses

60.4 M 49.5 M 32.4 M 29.2 M 14.6 M 8.12 M 6.41 M - - - - - -

All numbers in USD currency

Quarterly Income Statement Bicycle Therapeutics plc

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

69 M 52 M 42.6 M 42.4 M 39.6 M 30.2 M 30 M 29.9 M 29.7 M 29.6 M 29.6 M 29.6 M 25 M 24.1 M 22.1 M 21.1 M 19.4 M 18.1 M 18 M 17.9 M 17.9 M 7.3 M 834 K 503 K 434 K 420 K 397 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-50.8 M -39.8 M -26.6 M - -49.9 M -42.6 M -39.1 M - -28.3 M -26.8 M -27.6 M - -14.7 M -17.9 M -16.2 M -17.4 M -10.1 M -12.1 M -11.3 M -4.41 M -9.48 M -10.2 M -6.5 M -6.64 M -7.69 M -4.98 M -2.53 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

2.68 M 9.36 M 19.5 M - 5.35 M 11.4 M 4.9 M - 3.04 M 4.38 M 3.86 M - 4.33 M 1.78 M 1.81 M 3.85 M 3.84 M 1.57 M 1.13 M 5.28 M 614 K 1.52 M 6.38 M 1.06 M 1.61 M 1.66 M 2.81 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-63.8 M -46.6 M -31.7 M - -50.8 M -43.1 M -41.8 M - -29.8 M -27.3 M -27.4 M - -14.3 M -17.3 M -16 M - -10.7 M -12.6 M -11.6 M - -10.3 M -7.99 M -3.29 M - -6.36 M -4.96 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

- - 821 K - 814 K 821 K 808 K - 817 K 883 K 818 K - 823 K 819 K 522 K - - - - - -5.38 M -2.18 M -3.19 M - -1.36 M -73 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-61.6 M -45 M -30.1 M - -49.1 M -41.5 M -40.2 M - -28.5 M -26.7 M -27 M - -13.3 M -17 M -15.7 M - -9.73 M -12 M -11.3 M - -9.57 M -7.54 M -3.08 M - -5.83 M -4.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

66.5 M 56 M 51.2 M - 56.1 M 54.5 M 46.7 M - 32.8 M 31.7 M 31.2 M - 18.6 M 19.1 M 17.8 M 20.9 M 14.5 M 14.2 M 12.8 M 10 M 10.9 M 9.51 M 9.68 M 8.6 M 7.97 M 6.62 M 5.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

18.3 M 15.9 M 16.4 M - 16.3 M 14.8 M 14.5 M - 10 M 11.8 M 17 M - 8.11 M 7.34 M 8.14 M - 7.15 M 6.2 M 5 M - 4.79 M 2.97 M 3.4 M - 2.32 M 1.7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency